Antacids Containing Magnesium Interactions

Do not co-administer intravenous levofloxacin in the same IV line with magnesium or other multivalent cations.

Source: NLP:levofloxacin

Magnesium-containing preparations may cause hypermagnesemia and should not be taken during calcitriol therapy in chronic renal dialysis patients.

Source: NLP:calcitriol

Magnesium-containing preparations (e.g., antacids) should not be taken during calcitriol therapy in chronic renal dialysis patients due to risk of hypermagnesemia.

Source: NLP:calcitriol capsules 0.25 mcg

May enhance rocuronium bromide activity and neuromuscular blockade.

Source: NLP:rocuronium bromide

Reduces rate and extent of cefdinir absorption by approximately 40% and prolongs time to peak concentration by 1 hour. No significant effect if administered 2 hours before or after cefdinir.

Source: NLP:cefdinir

Magnesium should not be co-administered with intravenous delafloxacin through the same intravenous line due to chelation with multivalent cations.

Source: NLP:delafloxacin meglumine

Concomitant administration of high doses of magnesium-containing products may increase the risk of hypermagnesemia. Avoid use in chronic renal dialysis patients.

Source: NLP:doxercalciferol

Absorption of tetracyclines is impaired by antacids containing magnesium.

Source: NLP:doxycycline

Magnesium-containing antacids impair absorption of tetracyclines.

Source: NLP:doxycycline hyclate

Antacids containing magnesium impair absorption of tetracyclines.

Source: NLP:minocycline hydrochloride

Magnesium-containing antacids may bind phosphate and prevent its absorption.

Source: NLP:potassium phosphate, monobasic and sodium phosphate, monobasic, anhydrous

Decreases raltegravir plasma concentrations. Coadministration or staggered administration not recommended.

Source: NLP:raltegravir

Coadministration may impair SEYSARA absorption and decrease efficacy. Separate dosing required.

Source: NLP:sarecycline hydrochloride

May bind phosphate and prevent its absorption.

Source: NLP:dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

Magnesium may reduce absorption of CUVRIOR. If concomitant use unavoidable, separate administration by at least 1 hour before or 2 hours after.

Source: NLP:trientine tetrahydrochloride